This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nicoli, S. Articles by Presta, M. Search for Related Content PubMed PubMed Citation Articles by Nicoli, S. Articles by Presta, M.

Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos

¹ Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy; ² Department of Human Anatomy and Histology, University of Bari, Bari, Italy; and ³ Department of Biology, University of Milano, Milan, Italy

Requests for reprints: Marco Presta, Unit of General Pathology, Department of Biomedical Sciences and Biotechnology, Viale Europa 11, 25123 Brescia, Italy. Phone: 39-030371-7311; Fax: 39-030370-1157; E-mail: presta{at}med.unibs.it.

The zebrafish (Danio rerio)/tumor xenograft model represents a powerful new model system in cancer. Here, we describe a novel exploitation of the zebrafish model to investigate tumor angiogenesis, a pivotal step in cancer progression and target for antitumor therapies. Human and murine tumor cell lines that express the angiogenic fibroblast growth factor (FGF) 2 and/or vascular endothelial growth factor (VEGF) induce the rapid formation of a new microvasculature when grafted close to the developing subintestinal vessels of zebrafish embryos at 48 h postfertilization. Instead, no angiogenic response was exerted by related cell clones defective in the production of these angiogenic growth factors. The newly formed blood vessels sprout from the subintestinal plexus of the zebrafish embryo, penetrate the tumor graft, and express the transcripts for the zebrafish orthologues of the early endothelial markers Fli-1, VEGF receptor-2 (VEGFR2/KDR), and VE-cadherin. Accordingly, green fluorescent protein–positive neovessels infiltrate the graft when tumor cells are injected in transgenic VEGFR2:G-RCFP zebrafish embryos that express green fluorescent protein under the control of the VEGFR2/KDR promoter. Systemic exposure of zebrafish embryos immediately after tumor cell injection to prototypic antiangiogenic inhibitors, including the FGF receptor tyrosine kinase inhibitor SU5402 and the VEGFR2/KDR tyrosine kinase inhibitor SU5416, suppresses tumor-induced angiogenesis without affecting normal blood vessel development. Accordingly, VE-cadherin gene inactivation by antisense morpholino oligonucleotide injection inhibits tumor neovascularization without affecting the development of intersegmental and subintestinal vessels. These data show that the zebrafish/tumor xenograft model represents a novel tool for investigating the neovascularization process exploitable for drug discovery and gene targeting in tumor angiogenesis. [Cancer Res 2007;67(7):2927–31]

This article has been cited by other articles:

				C. Urbinati, S. Nicoli, M. Giacca, G. David, S. Fiorentini, A. Caruso, M. Alfano, L. Cassetta, M. Presta, and M. Rusnati HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium Blood, October 8, 2009; 114(15): 3335 - 3342. [Abstract] [Full Text] [PDF]

				S. Hasegawa, K. Maruyama, H. Takenaka, T. Furukawa, and T. Saga A medaka model of cancer allowing direct observation of transplanted tumor cells in vivo at a cellular-level resolution PNAS, August 18, 2009; 106(33): 13832 - 13837. [Abstract] [Full Text] [PDF]

				S. Nicoli, C. Tobia, L. Gualandi, G. De Sena, and M. Presta Calcitonin receptor-like receptor guides arterial differentiation in zebrafish Blood, May 15, 2008; 111(10): 4965 - 4972. [Abstract] [Full Text] [PDF]

				G. A. Geiger, W. Fu, and G. D. Kao Temozolomide-Mediated Radiosensitization of Human Glioma Cells in a Zebrafish Embryonic System Cancer Res., May 1, 2008; 68(9): 3396 - 3404. [Abstract] [Full Text] [PDF]

				H. Feitsma and E. Cuppen Zebrafish as a Cancer Model Mol. Cancer Res., May 1, 2008; 6(5): 685 - 694. [Abstract] [Full Text] [PDF]

				S. Cermenati, S. Moleri, S. Cimbro, P. Corti, L. Del Giacco, R. Amodeo, E. Dejana, P. Koopman, F. Cotelli, and M. Beltrame Sox18 and Sox7 play redundant roles in vascular development Blood, March 1, 2008; 111(5): 2657 - 2666. [Abstract] [Full Text] [PDF]

				K. Stoletov, V. Montel, R. D. Lester, S. L. Gonias, and R. Klemke High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish PNAS, October 30, 2007; 104(44): 17406 - 17411. [Abstract] [Full Text] [PDF]